Familial partial lipodystrophy (Dunnigan syndrome) due to LMNA gene mutation: The first description of its clinical case in Russia

被引:8
|
作者
Sorkina, E. L. [1 ]
Kalashnikova, M. F. [1 ]
Melnichenko, G. A. [1 ,2 ]
Tyulpakov, A. N. [2 ]
机构
[1] IM Sechenov First Moscow State Med Univ, Minist Hlth Russia, Fac Therapeut, Dept Endocrinol, Moscow, Russia
[2] Minist Hlth Russia, Endocrinol Res Ctr, Moscow, Russia
关键词
lipodystrophy; LMNA; insulin resistance; diabetes mellitus; acanthosis nigricans; LAMIN A/C;
D O I
10.17116/terarkh201587383-87
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hereditary lipodystrophies (HLD) are a heterogeneous group of rare diseases characterized by a complete or partial loss of subcutaneous fat and by the development of metabolic disturbances: diabetes mellitus with obvious insulin resistance and acanthosis nigricans, dyslipidemia, hepatic steatosis, hypertension, and polycystic ovary syndrome. The laminopathy variant familial partial lipodystrophy type 2 or Dunnigan syndrome (FPLD2) is the most common cause of partial LD. The paper describes a family (3 clinical cases) with FPLD2 caused by heterozygous R482W missense mutations in the gene encoding the protein lamin A/C (LMNA; 150330). This observation demonstrates that specialists should be more aware of this disease and make a timely diagnose in cases of concurrent severe metabolic disturbances at a young age, which contributes to more effective treatment of patients and to medical genetic counseling of their families.
引用
收藏
页码:83 / 87
页数:5
相关论文
共 50 条
  • [21] A case of familial partial lipodystrophy caused by a novel lamin A/C (LMNA)mutation in exon 1 (D47N)
    Kutbay, Nilufer Ozdemir
    Yurekli, Banu Sarer
    Onay, Huseyin
    Altay, Canan Tuncer
    Atik, Tahir
    Hekimsoy, Zeliha
    Saygili, Fusun
    Akinci, Baris
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 29 : 37 - 39
  • [22] Unusual case of polycystic ovary syndrome (PCOS) and gestational diabetes as a result of familial partial lipodystrophy type 2 (FPLD2) due to heterozygous missense mutation R482W in LMNA gene, described for the first time in Russian population
    Sorkina, E.
    Tiulpakov, A.
    Kalashnikova, M.
    Burumkulova, F.
    Petrukhin, V.
    Melnichenko, G.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (03)
  • [23] Clinical characteristics and efficacy of pioglitazone in a Japanese patient with familial partial lipodystrophy due to peroxisome proliferator-activated receptor γ gene mutation
    Iizaka, Toru
    Kodama, Eriko
    Mikura, Kentaro
    Iida, Tatsuya
    Imai, Hideyuki
    Hashizume, Mai
    Kigawa, Yasuyoshi
    Sugisawa, Chiho
    Tadokoro, Rie
    Endo, Kei
    Otsuka, Fumiko
    Isoda, Masayo
    Ebihara, Ken
    Ishibashi, Shun
    Nagasaka, Shoichiro
    ENDOCRINE JOURNAL, 2023, 70 (01) : 69 - 76
  • [24] Dunnigan-type familial partial lipodystrophy (FPLD): a monogenic syndrome of central fat accumulation and insulin resistance due to mutations in nuclear lamin A.
    Hegele, RA
    OBESITY RESEARCH, 2000, 8 : 3S - 3S
  • [25] Clinical characteristics and efficacy of pioglitazone in a Japanese patient with familial partial lipodystrophy due to peroxisome proliferator-activated receptor γ gene mutation
    Iizaka, Toru
    Kodama, Eriko
    Mikura, Kentaro
    Iida, Tatsuya
    Imai, Hideyuki
    Hashizume, Mai
    Kigawa, Yasuyoshi
    Sugisawa, Chiho
    Tadokoro, Rie
    Endo, Kei
    Otsuka, Fumiko
    Isoda, Masayo
    Ebihara, Ken
    Ishibashi, Shun
    Nagasaka, Shoichiro
    ENDOCRINE JOURNAL, 2022, : 69 - 76
  • [26] Comparison of Phenotypes in Male and Female Individuals of a New Family with Dunnigan Type of Familial Partial Lipodystrophy Due to a Lamin A/C R482W Mutation
    Laudes, M.
    Oberhauser, F.
    Walgenbach, K.
    Schubert, M.
    Schulte, D. M.
    Faust, M.
    Krone, W.
    HORMONE AND METABOLIC RESEARCH, 2009, 41 (05) : 414 - 417
  • [27] Clinical variability of familial partial lipodystrophy (Kobberling-Dunnigan syndrome) in 3 families from the Ribeirao Preto region, Sao Paulo, Brazil
    Foss, MC
    Montenegro, RM
    Paccola, GMFG
    Gouveia, LMFB
    Acosta, AX
    DIABETOLOGIA, 2001, 44 : A225 - A225
  • [28] Case Report: An Atypical Form of Familial Partial Lipodystrophy Type 2 Due to Mutation in the Rod Domain of Lamin A/C
    Cecchetti, Carolina
    D'Apice, M. Rosaria
    Morini, Elena
    Novelli, Giuseppe
    Pizzi, Carmine
    Pagotto, Uberto
    Gambineri, Alessandra
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [29] Clinical characteristics in two patients with partial lipodystrophy and Type A insulin resistance syndrome due to a novel heterozygous missense mutation in the insulin receptor gene
    Iwanishi, Masanori
    Kusakabe, Toru
    Azuma, Choka
    Tezuka, Yuji
    Yamamoto, Yukako
    Ito-Kobayashi, Jun
    Washiyama, Miki
    Morimoto, Mayumi
    Ebihara, Ken
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 152 : 79 - 87
  • [30] A UNIQUE CASE OF A PATIENT WITH PARTIAL TRISOMY 22 AND LIPODYSTROPHY: IS IT A NEW SYNDROME DUE TO AN IGF-IR MUTATION?
    Caglayan, A. O.
    Klammt, J.
    Kiess, W.
    Hatipoglu, N.
    Pfaeffle, R.
    Kurtoglu, S.
    Saatci, C.
    Dundar, M.
    GENETIC COUNSELING, 2010, 21 (02): : 187 - 197